Narrative Review of Opioid Use Disorder Treatment Changes During the COVID-19 Pandemic and Their Impact on American Indian/Alaska Native Communities.  Bingham-Hendricks C, Peters-Mosquera A, Aronowitz SV, Woods C, Aronowitz T.  Nurs Open…

Adapting opioid therapy: real-world analysis of switching from methadone to slow-release morphine and back amid COVID-19 supply chain disruptions.  Barkus A, Subata E, Jakavičius H, Barkienė L, Lydekaitė E, Zdanavičius L, Likatavičius G, Širvi…

Rurality weakens the positive association between the COVID-19 pandemic and substance use treatment involving medications for opioid use disorder.  Lofaro RJ, Confer LM, Bohler RM, Schwind JS.  Drug Alcohol Depend Rep. 2026 Jan 5;18:1004…

The role of opioid treatment programs' crisis response on client perceptions of risk and impact.  Frimpong JA, Archer MT, Kong Y, Khachikian T, Wang S, Howard DL.  BMC Public Health. 2025 Dec 12. doi: 10.1186/s12889-025-25735-0. Epub ahe…

Impact of COVID-19 lockdown on methadone and buprenorphine prescriptions in England primary cares: an interrupted time series analysis.  Chang YC, Liao WC, Chen LC, Chen TC.  Harm Reduct J. 2025 Nov 25. doi: 10.1186/s12954-025-01354-1. E…

Impacts of Disruptive Events on Addictive Behavioral Patterns: A Cross-Sectional Study of Methadone Maintenance Therapy During the COVID-19 Pandemic in Iran.  Toreyhi Z, Rezai-Mersagh AM, Kheradmand A, Mehrvar R.  Health Sci Rep. 2025 No…